Efficacy News and Research

RSS
Cannabis temporarily reduces severity of PTSD symptoms

Cannabis temporarily reduces severity of PTSD symptoms

Probiotics are not recommended for most digestive conditions

Probiotics are not recommended for most digestive conditions

Old antibiotic may be a powerful new tool against deadly superbug

Old antibiotic may be a powerful new tool against deadly superbug

Novel compound shows promise for ANCA-associated vasculitis

Novel compound shows promise for ANCA-associated vasculitis

Using antibodies to detect Alzheimer’s disease

Using antibodies to detect Alzheimer’s disease

Tocilizumab in COVID-19 patients on mechanical ventilation

Tocilizumab in COVID-19 patients on mechanical ventilation

New strategy may facilitate development of multi-epitope peptide vaccine against SARS-CoV-2

New strategy may facilitate development of multi-epitope peptide vaccine against SARS-CoV-2

Approved drug could help dampen massive immune response associated with severe COVID-19

Approved drug could help dampen massive immune response associated with severe COVID-19

Volcanic glass spray effective in controlling mosquitoes

Volcanic glass spray effective in controlling mosquitoes

New study highlights the credibility of registered clinical trials

New study highlights the credibility of registered clinical trials

Antiviral effects for COVID-19: Early is better

Antiviral effects for COVID-19: Early is better

Trial results show efficacy of netakimab for treating moderate-to-severe plaque psoriasis

Trial results show efficacy of netakimab for treating moderate-to-severe plaque psoriasis

U.K. doctors test lipid ibuprofen as COVID-19 treatment

U.K. doctors test lipid ibuprofen as COVID-19 treatment

Assessing the integrity of remdesivir clinical trial during COVID-19 pandemic

Assessing the integrity of remdesivir clinical trial during COVID-19 pandemic

Designing a prototype spike protein vaccine for SARS-CoV-2

Designing a prototype spike protein vaccine for SARS-CoV-2

Intranasal delivery of MSC-EVs shows promise for treating Alzheimer's disease

Intranasal delivery of MSC-EVs shows promise for treating Alzheimer's disease

Immune responsive nanoparticles for COVID-19 vaccine delivery

Immune responsive nanoparticles for COVID-19 vaccine delivery

World’s first study of potential antibody therapy to fight COVID-19 begins in humans

World’s first study of potential antibody therapy to fight COVID-19 begins in humans

Pre-clinical data for Celltrion’s antiviral antibody treatment shows 100-fold reduction in viral load of SARS-CoV-2

Pre-clinical data for Celltrion’s antiviral antibody treatment shows 100-fold reduction in viral load of SARS-CoV-2

Health care providers urged to stop hydroxycholoroquine use for COVID-19

Health care providers urged to stop hydroxycholoroquine use for COVID-19

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.